Pathophysiology and Lung-Injury Mechanisms in Inhalation Injury

Overview¶

Inhalation injury is best understood not as a single insult but as a complex of disease processes that unfold over time after smoke exposure ^[2]. By definition it is airway and lung-parenchyma injury plus general chemical damage produced by inhaling toxic gases and the products of incomplete combustion ^[1]. Three injuries arrive together and on different clocks: thermal injury to the upper airway within minutes, chemical injury to the tracheobronchial tree and lung over hours, and systemic asphyxiant toxicity from carbon monoxide and cyanide that can kill at the scene before any lung lesion matters ^[22].

The clinical weight of this disease is hard to overstate. Across five decades of literature, inhalation injury is named the most frequent and serious comorbid event in thermally injured patients ^[3], an important contributor to morbidity and mortality that can trigger acute lung injury (ALI) and ARDS ^[4], and one of the classic determinants of burn mortality alongside age and burn size ^[23]. It is the most common cause of death among burn patients who are fire victims ^[24]. Yet advances in inhalation-injury care have not kept pace with the gains made in cutaneous burn treatment ^[25], which is part of why it remains a persistent driver of multiple-organ dysfunction and death even in the modern burn unit.

This page is about mechanism: how heat, smoke, and the body's inflammatory response convert an inhaled insult into a failing lung. The teaching point that organizes everything below is that the dominant early lesion is in the airway, not the alveolus, and that the parenchymal catastrophe usually requires a second hit. Most of what is known mechanistically comes from the chronically instrumented sheep model, and that provenance is named throughout rather than hidden.

Epidemiology¶

Inhalation injury complicates roughly one-third of major burns, with cited ranges spanning 10 to 30 percent of burn-center admissions ^[26] and about 30 percent of patients with major burns ^[28]. When diagnosis rests on bronchoscopy and radioisotope scanning rather than clinical suspicion, the figure settles near 30 percent of major burns ^[10]. Its presence is an independent predictor of mortality that adds to, rather than overlaps with, age and total body surface area (TBSA) burned ^[23].

The size of that mortality penalty is one of the more contested numbers in burn care. Older series attributed anywhere from 20 to 84 percent of burn mortality to inhalation injury and described it adding up to a 20 percent absolute increase over what age and burn extent predict ^[28][29][26]. Modern adjusted analyses are more disciplined: inhalation injury independently roughly doubles the risk of death (relative risk about 2.08) ^[23], with in-hospital mortality near 23 percent in affected patients ^[30]. The literature itself flags that the older attributable-mortality estimates likely overstate the effect and that recent cohorts trend lower ^[26]. Mortality also rises in a dose-response with bronchoscopic grade rather than as a simple yes-or-no ^[27].

The complication burden scales with the injury. Burn patients carry the highest ARDS incidence of any predisposing condition ^[31], and inhalation injury increases oxygenation and fluid requirements, pulmonary complications, MODS risk, and overall mortality ^[32]. Risk rises with closed-space exposure, larger and deeper burns, advancing age, and a flame mechanism ^[33]. Two cautions belong with any epidemiologic figure here: administrative diagnosis codes capture burn size and mechanism well but identify inhalation injury poorly, so registry surveillance undercounts it ^[105], and there is still no worldwide consensus on how the injury is diagnosed or graded ^[18].

Pathophysiology¶

The pathophysiology is the heart of this topic, so it is worth stating the through-line before the detail. Smoke injures the airway first. Heat takes the upper airway; toxic combustion products take the airway below the cords. The injured airway then exports its damage to the lung parenchyma through a hyperemic, leaky bronchial circulation and through a diffuse inflammatory and nitrosative-oxidative response, producing a high-permeability pulmonary edema, surfactant loss, and a ventilation-driven gas-exchange failure. A concomitant cutaneous burn and later sepsis convert this airway-centered process into ARDS and multi-organ failure. Most of the mechanistic evidence below comes from the ovine smoke-inhalation model, and that is named where it matters.

Upper-airway thermal injury and supraglottic edema¶

The upper airway above the vocal cords is the principal site of thermal injury ^[34], because the supraglottic airway absorbs and dissipates inhaled heat efficiently ^[9]. Thermal injury below the cords is rare precisely because of this effective heat dissipation ^[9]; experimental work shows airway mucosa is unexpectedly resistant to dry heated air, with mucosal surface temperature rising only slowly even during sustained exposure ^[35]. The clinically important exception is steam, which carries far more heat and is the one vector capable of inflicting direct thermal damage below the cords; most of what reaches the lower airway is not heat but the products of incomplete combustion, chiefly aldehydes ^[10].

The lesion that threatens the airway is edema, and it progresses on a delay. Supraglottic and glottic erythema and edema can advance over hours to boggy, occlusive swelling that obliterates the aryepiglottic folds and arytenoid eminences and prolapses to close the airway ^[36]. Critically, this progression correlates with larger cutaneous burns, face and neck burns, and a more rapid rate of intravenous fluid resuscitation ^[36]. That correlation reframes upper-airway obstruction as partly a fluid-driven, time-delayed phenomenon rather than a purely thermal burn of the airway, which is why the swelling can outrun an early reassuring examination.

Tracheobronchial mucosal injury, epithelial sloughing, and obstructive casts¶

Below the cords the injury is chemical, not thermal, and the hallmark lesion is a necrotizing, membranous tracheobronchitis ^[12]. The columnar ciliated epithelium sloughs, often coming away intact with cilia still beating, which implicates loss of attachment to the basal lamina rather than outright cell death; within a day of injury the columnar epithelium can shed intact from the trachea with a roughly 35 percent reduction in the basal-cell population ^[37]. The ovine work pins this to a measurable loss of desmosomal adhesion between columnar and basal cells ^[38]. The denuded mucosa then mixes with mucus, fibrin, neutrophils, and protein-rich exudate to form obstructive tracheobronchial casts ^[12][39].

These casts are the engine of progressive hypoxia. The loss of respiratory epithelium and formation of casts is perhaps the most significant pathologic change in the injury ^[11], and small-airway occlusion by edema and pseudomembrane is the primary mechanism by which hypoxia worsens ^[40]. The obstructive burden is also the strongest morphologic predictor of gas-exchange failure: in the ovine model, airway-obstruction scores correlate with the PaO2/FiO2 ratio at r equal to 0.76, and both bronchial and bronchiolar obstruction scores predict oxygenation ^[15]. The casts also shift in composition and location over time, with bronchial obstruction maximal around 24 hours and largely mucus, while bronchiolar obstruction increases later and is principally neutrophilic ^[15]. Repair proceeds by proliferation and differentiation of surviving nonciliated cells back toward a normal phenotype ^[37].

Bronchial blood flow: the multi-fold increase and its consequences¶

One of the defining, near-immediate responses to smoke inhalation is a massive, selective increase in bronchial (systemic airway) blood flow. In sheep, airway blood flow rises roughly 8-fold in the main-stem bronchi and as much as 12-fold in intraparenchymal bronchi after injury, and this results from selective vasodilation of the airway vasculature rather than any rise in arterial driving pressure ^[13]. The increase is brisk, peaking about 20 minutes after the insult ^[41], and it is sustained at a multi-fold level for the first day. In burned sheep, smoke inhalation produces a greater-than-tenfold increase in bronchial blood flow ^[42].

This matters because of where that blood goes. Bronchial venous drainage empties into the pulmonary microvasculature, so a hyperemic, leaky bronchial circulation delivers plasma filtrate, inflammatory mediators, and cytotoxins directly into the lung parenchyma ^[43]. The bronchial circulation is therefore mechanistically upstream of pulmonary edema rather than a bystander. The causal role is established by intervention: occlusion, ligation, ablation, or ethanol sclerosis of the bronchial artery reduces lung lymph flow, extravascular lung water, airway obstruction, and gas-exchange deterioration, and bronchial-artery sclerosis significantly improves pulmonary function in the model ^[42]. The hyperemia is driven in large part by inducible nitric oxide synthase (iNOS)-derived nitric oxide in the airway circulation, which is the link between this mechanism and the reactive-species section below ^[44].

Microvascular permeability and pulmonary edema¶

The pulmonary edema of smoke inhalation is a high-permeability, non-cardiogenic edema. The signature is unambiguous in the lung-lymph-fistula sheep: lung lymph flow rises several-fold, the lymph-to-plasma protein ratio increases, and transvascular protein flux climbs, all while pulmonary vascular pressures stay near baseline ^[14]. The osmotic reflection coefficient falls toward 0.48 as lymph flow rises, quantifying the loss of barrier selectivity ^[45]. Both increased permeability and increased capillary pressure contribute, and their relative shares shift over time, from roughly two-thirds permeability and one-third pressure at 24 hours toward a pressure-dominant pattern by 48 hours ^[46].

The clinically decisive modifier is the cutaneous burn. Isolated smoke inhalation produces only a modest rise in extravascular lung water unless it is accompanied by a major surface burn ^[47], and the combined injury roughly doubles lung lymph flow and net fluid retention beyond what either injury produces alone ^[48]. The added severity of the combined-injury edema is driven mainly by augmented microvascular permeability to fluid rather than to protein ^[49]. This is also where the human and animal literatures appear to disagree: several clinical studies found little early increase in lung water from inhalation alone and attributed most delayed extravascular-lung-water rises to sepsis ^[50]. The reconciliation is the airway-first, second-hit framing: the early lesion is in the airway, and a parenchymal permeability catastrophe usually requires a second burn or septic hit.

Alveolar injury, surfactant dysfunction, and atelectasis¶

Beyond the airway, smoke injures the alveolar compartment by two converging routes. The first is direct cytotoxic damage to the type I pneumocyte: intracellular edema with bleb and vesicle formation is an early and prominent lesion in the type I cell, while the capillary endothelium is relatively spared, supporting an epithelium-first mechanism analogous to ammonia and nitric-acid injury ^[51]. Smoke also increases alveolar epithelial permeability to protein and reduces alveolar fluid-clearance capacity ^[52]. The second route is surfactant inactivation: minimum surface tension rises and surfactant function falls, producing alveolar instability, atelectasis, reduced compliance, and worsened oxygenation ^[53]. Exogenous surfactant can restore function in selected models, but the signal is product-dependent, with Infasurf restoring dynamic surface tension while Exosurf was ineffective against wood smoke ^[54][55].

The teaching nuance is that a primary alveolar oxygenation lesion is not the dominant early event. Parenchymal injury and alveolar flooding generally require an added inflammatory or septic hit, which is what distinguishes smoke ARDS from the classic shunt-driven ARDS of oleic-acid models.

Reactive species: nitric oxide, peroxynitrite, and oxidative stress¶

Reactive oxygen and nitrogen species are central effectors, not epiphenomena. Excess nitric oxide, generated chiefly by iNOS induced in airway epithelium, glands, and macrophages, combines with superoxide to form peroxynitrite, and the combined burn-and-smoke injury raises NOx and lung 3-nitrotyrosine many-fold while severely impairing hypoxic pulmonary vasoconstriction ^[16]. Causality is established by inhibition: blocking iNOS significantly suppresses the rise in pulmonary microvascular permeability, and iNOS-derived nitric oxide is important in both systemic and pulmonary permeability after combined injury ^[56]. A defined contribution comes from neuronal NOS as well, whose inhibition attenuates the observed pulmonary pathophysiology ^[57]; a selective neuronal-NOS inhibitor prevents the iNOS and nitrotyrosine changes and restores hypoxic pulmonary vasoconstriction ^[58]. Peroxynitrite itself plays a crucial role in microvascular hyperpermeability and dysfunction ^[59], and the reactive-nitrogen pathway is corroborated by elevated airway nitrotyrosine after smoke and burn ^[60].

Oxidant stress runs in parallel. When arginine availability falls, NOS produces superoxide instead of nitric oxide, and supplying L-arginine improves gas exchange and obstruction through the peroxynitrite pathway ^[61]. A consistent and clinically humbling finding is that after isolated smoke the direct oxidant activity localizes to the airway surface, with lung-tissue lipid peroxidation not increased despite severe airway injury ^[62]; adding a burn is what raises parenchymal lipid peroxidation, again pointing to a systemic rather than purely local oxidant mechanism ^[63]. Antioxidants are protective in the model: vitamin E pretreatment reduces the permeability index, lymph flow, conjugated dienes, and nitrotyrosine and improves oxygenation ^[64].

Inflammation: neutrophils, eicosanoids, cytokines, and PARP¶

Inflammation is the engine that converts a focal airway insult into diffuse lung injury. Neutrophils are sequestered and activated in the pulmonary microcirculation and airway, and a neutrophil-mediated process causes a major fraction of the edema after smoke inhalation ^[65]. The causal evidence is again interventional: leukocyte depletion attenuates the rise in pulmonary artery pressure, vascular resistance, and lymph flow, while protease inhibition blunts the transvascular-flux increase ^[65]. A protease-antiprotease imbalance, with rising bronchoalveolar elastase and falling antiprotease activity, correlates with extravascular lung water ^[66]. Eicosanoids of the cyclooxygenase pathway, especially thromboxane A2, mediate the rise in pulmonary and systemic vascular resistance and promote platelet microaggregation ^[67]; a dissociation worth teaching is that thromboxanes drive vascular tone but play no role in edema formation ^[67]. Cytokines rise early, with smoke priming alveolar leukocytes for an enhanced cytokine response and increased TNF-alpha, IL-6, and IL-8 ^[68]. PARP, activated by oxidant and nitrosative DNA damage, parallels reactive-species generation in leukocytes and is a validated therapeutic node ^[69]. Alveolar macrophages are simultaneously primed and functionally suppressed, phagocytosing and killing bacteria less effectively after smoke exposure, which helps explain the susceptibility to infection ^[70].

Gas-exchange derangement¶

The characteristic gas-exchange lesion is a ventilation disturbance from airway obstruction, not a shunt-dominated lesion. Smoke inhalation increases blood flow to low-ventilation-perfusion compartments, but true shunt (a ventilation-perfusion ratio of zero) is not a consistent finding, which distinguishes it from most ARDS and oleic-acid edema where true shunt is the major hypoxia mechanism ^[40]. The early disturbance is one of ventilation, with recruitment of blood flow to low-V/Q units as bronchial obstruction and alveolar derecruitment supervene ^[71]. Early changes also include high-V/Q and dead-space ventilation from regional vasospasm, evolving to low-V/Q perfusion, with true intrapulmonary shunting notably absent early ^[72]. PaO2 and the PaO2/FiO2 ratio then fall progressively, often after a deceptive latent interval, explained partly by loss of hypoxic pulmonary vasoconstriction so that blood gases stay physiologic and then suddenly deteriorate ^[16]. Because the lesion is ventilation- rather than shunt-driven, inhaled nitric oxide gives only modest and inconsistent benefit to oxygenation, improving V/Q matching by selective vasodilation of ventilated areas without addressing the airway obstruction ^[71]. The degree of airway obstruction predicts the PaO2/FiO2 ^[15].

Systemic and cardiovascular effects¶

Smoke inhalation is not confined to the lung. It triggers a systemic inflammatory response with a markedly increased oxygen consumption and fluid requirement, and the magnitude of these systemic changes scales with the degree of airway inflammation rather than with alveolar dysfunction or gas-phase toxins such as carbon monoxide ^[73]. In the model, a defined smoke dose can drive a 100 percent increase in oxygen consumption and triple the fluid requirement ^[73], and filtered smoke that spares the airway produces only the burn-alone systemic response, implicating airway-derived mediators as the systemic trigger ^[8]. There is a delayed myocardial depression: maximum left-ventricular contractility falls after smoke but not after carbon monoxide alone ^[74], and this later cardiac depression is mediated by iNOS-derived nitric oxide ^[75]. The injury also produces splanchnic vasoconstriction with increased bacterial translocation, more so when a thermal injury is added ^[76], linking the lung injury to gut-derived sepsis. Sepsis, in turn, is the dominant cause of the later and larger increases in lung water ^[50].

The ovine model and what it established¶

The chronically instrumented sheep lung-lymph-fistula preparation is the workhorse that built the modern mechanistic picture, because it reproduces the human pathophysiology while allowing direct measurement of lymph flow, permeability coefficients, and regional blood flows ^[14][77]. The same pathophysiologic alterations seen clinically in humans occur in the model: diffuse mucosal sloughing, edema from increased microvascular permeability, and progressive hypoxemia ^[77]. The model defined the four-phase morphologic sequence of the injury ^[78] and served as the platform on which the neutrophil, protease, eicosanoid, iNOS, peroxynitrite, PARP, and antioxidant mechanisms above were each tested by intervention. Refinements added a cutaneous burn, and later pneumonia and sepsis, to model the clinically lethal combined injury and to standardize the time to ARDS ^[79]. The honest caveat, which the model's own investigators raise, is that it lacks full standardization, a meaningful fraction of animals fail to meet ARDS criteria, and a second-hit insult is needed to produce parenchymal ARDS ^[80].

Classification¶

Inhalation injury is classified along several axes that map directly onto the mechanisms above. The anatomic axis divides injury into supraglottic, subglottic, and systemic classes, each producing inflammation, airway obstruction, and impaired gas exchange ^[22]. The temporal axis describes three overlapping clinical stages: early bronchospasm in the first 1 to 12 hours, pulmonary edema at roughly 6 to 72 hours, and bronchopneumonia after about 60 hours ^[81]. The injury-type axis separates direct thermal damage, chemical and particulate injury from combustion products, and the systemic asphyxiant toxicity of carbon monoxide and cyanide ^[22].

For severity, the bronchoscopic Abbreviated Injury Score (AIS, grades 1 to 4) is the most widely used grading system and fiberoptic bronchoscopy is the diagnostic reference standard ^[82]. Grade carries prognostic weight that is mechanistically coherent: despite matched TBSA, higher bronchoscopic grades have significantly worse survival than low grades ^[32], and high grades carry markedly higher pneumonia and ARDS risk ^[82]. An alternative mucosal-depth grading shows the same dose-response, with deeper mucosal injury mapping to a steeply higher ALI rate ^[83]. The detailed mechanics of these grading systems, their inter-rater reliability, and their diagnostic accuracy belong to the sibling diagnosis-and-grading page; the point here is only that severity tracks the depth of the airway lesion.

Assessment¶

This is a mechanism page, so assessment is framed as the bedside readout of the underlying lesions rather than as a diagnostic protocol. The hallmark physiologic derangement is a mixed restrictive-obstructive defect with severe hypoxemia: a falling PaO2/FiO2 ratio, a rising shunt fraction, and declining compliance are the bedside signature of increased alveolar-capillary permeability, V/Q mismatch from bronchiolar obstruction, and lost hypoxic pulmonary vasoconstriction ^[15][16]. Because that loss of vasoconstriction defers the hypoxemia, oxygenation indices can lag the true injury, and hypoxemia appears earlier in patients with inhalation injury than without ^[84].

Carboxyhemoglobin illustrates the limits of a single number as a lung-injury surrogate. It indexes systemic asphyxiant load, correlating with global indices of pulmonary failure such as oxygenation, shunt, lung lymph flow, and wet-to-dry ratio, yet it shows no significant correlation with histopathology or airway-obstruction scores and cannot predict the degree of lung injury at 48 hours ^[85]. Bronchoscopic grade does track measured carboxyhemoglobin and the early gas-exchange indices, but the correlation with oxygenation is moderate ^[86]. The practical mechanistic lesson is that the external signals of exposure are not the same as the internal injury cascade, and the airway lesion that bronchoscopy visualizes is only the proximal part of a process that extends distally.

Management¶

Management is framed here through mechanism; pure ventilator-management, pharmacotherapy-efficacy, and antidote-outcome questions belong to the sibling management pages. The organizing reality is that there is no proven specific treatment for the injury itself, so management focuses on the nonspecific consequences and on support ^[5]. Mortality improvements over recent decades are attributed mostly to general advances in critical care rather than to focused inhalation-injury interventions ^[87].

Each management principle answers a specific mechanism. Airway protection is driven by the progressive, fluid-amplified supraglottic edema described above, which can outrun the examination ^[36]. Fluid management is a tension created by the permeability lesion: inhalation injury raises resuscitation requirements above the cutaneous-burn estimate because of the permeability-driven increase in systemic and pulmonary lymph flux ^[33], yet over-resuscitation worsens lung water, so ARDS development correlates with the actual resuscitation volume delivered despite normal filling pressures ^[88]. Ventilation strategy targets the cast-obstruction and heterogeneous-V/Q mechanisms, and in the ovine model immediate positive-pressure ventilation with PEEP after the insult improves short-term survival and decreases tracheobronchial cast formation ^[89]. The single best-validated therapeutic-mechanism target is the fibrin cast: clearance of obstructive cast material is described as crucial ^[90], reflecting that intraluminal fibrin deposition, not inflammation alone, is causally load-bearing in the obstruction pathway. Several mechanistic null results sharpen the picture, most importantly that methylprednisolone does not protect the lung from the acute consequences of the injury ^[91], ruling out a simple global-inflammation model.

Complications¶

The complications of inhalation injury are the downstream expression of its mechanisms, and each maps to a lesion described above.

Pneumonia is the dominant infectious sequela. Inflammatory occlusion of terminal bronchioles plus necrosis of the endobronchial mucosa render the airway and parenchyma susceptible to infection, and the resulting pneumonitis further increases mortality ^[29]. The cast and obstruction pathology links directly to infection, with bronchiolar obstruction scores far higher in victims with pneumonia than without ^[92]. Hyperglycemia is a mechanistic amplifier: airway and blood glucose above roughly 150 mg/dL fuels broncho-pulmonary bacterial overgrowth and raises pneumonia and ARDS rates ^[93]. Severity-graded data show a clear dose-response, with nosocomial pneumonia rising from 14 percent in patients without inhalation injury to 31 percent with low-grade and 48 percent with high-grade injury ^[17].

ARDS is the central parenchymal consequence, and its incidence climbs steeply with bronchoscopic grade ^[86]. Onset is characteristically early, typically within the first week, which reflects the direct permeability injury rather than later nosocomial drivers. Mechanistically, ARDS development is predicted by the actual fluid-resuscitation volume despite normal wedge and central venous pressures, the direct signature of increased microvascular permeability ^[88].

Mechanical airway obstruction is the most direct early complication: acute occlusion with sloughed bronchial mucosa, edema, and infection are the most common complications, and in severe ovine injury bronchial cast formation is itself lethal, driving respiratory failure despite vigorous pulmonary toilet ^[89]. Late airway sequelae form a distinct mechanistic category arising from mucosal necrosis and prolonged intubation, including tracheal stenosis and tracheoesophageal and tracheoarterial fistula ^[94]. Pulmonary edema is the most common early complication, while sepsis dominates the later course ^[95], and respiratory failure is the most common cause of death after thermal injury ^[96][97]. Survivors of severe injury can develop durable airway and parenchymal remodeling, including bronchiectasis and bronchiolitis obliterans, and in one series 95 percent of survivors had some restrictive ventilatory impairment with most also showing reduced diffusion capacity ^[98].

Special Considerations¶

Several subgroups warrant tailored vigilance, each for a mechanistic reason. In children, lung damage is the most frequent and largely unpreventable cause of burn death ^[20], and smoke inhalation injury remains a significant cause of pediatric pulmonary disease and mortality ^[31]. Pregnant patients face amplified carbon monoxide toxicity because fetal hemoglobin binds carbon monoxide 2.5- to 3-fold more avidly than maternal hemoglobin ^[21], so the fetal compartment is at risk even when maternal measures look reassuring. The synergy with a cutaneous burn is itself a special consideration that runs through the whole disease: the combined injury raises mortality, fluid needs, edema, and oxidant load beyond the sum of either injury alone, with survival falling to about 30 percent for the combined insult versus 60 to 70 percent for either injury alone in the model ^[7]. The mechanism page for systemic toxins and the population-specific management details are carried on the sibling pages; the mechanistic point is that these populations sit at the steep part of every dose-response curve described above.

Outcomes¶

Outcomes follow the mechanisms with quantitative fidelity. Inhalation injury is one of the three classic mortality determinants with age and TBSA, and modern adjusted analyses converge on it independently roughly doubling the risk of death ^[30][23]. Mortality rises in a strict dose-response with bronchoscopic injury grade rather than as a binary ^[32]. The defining outcome mechanism is synergy: combined cutaneous burn and smoke inhalation produce multiplicative rather than additive mortality, with survival dropping to 30 percent combined against 60 to 70 percent for single insults ^[7], and pulmonary complications causing or directly contributing to death in 77 percent of combined inhalation-and-burn injuries ^[88].

Once ARDS develops, mortality scales with severity along the Berlin gradient, providing a quantitative mechanism-to-outcome ladder ^[99]. Across cohorts, mortality rises stepwise from no-ARDS through mild, moderate, and severe disease, with moderate and severe ARDS multiplying the odds of death several-fold ^[99], and the Berlin definition stratifies severity better in burns than the older AECC definition ^[100]. A contemporary nuance qualifies this: several recent series report low mortality for early, permeability-driven ARDS regardless of the PaO2/FiO2 ratio, suggesting early injury-driven ARDS may be more recoverable than late infection-driven ARDS ^[101]. A distinct mortality mechanism is systemic asphyxiant toxicity rather than lung injury, since most fire fatalities result from inhaled toxic gases and carbon monoxide is the predominant cause of death among fire victims, explaining why many deaths occur before or independent of ARDS and pneumonia ^[102][6]. Finally, the injury's mortality is largely mediated through the respiratory failure it causes: in the absence of respiratory failure, inhalation injury does not appear to contribute independently to mortality ^[103].

Controversies and Evidence Gaps¶

The honest appraisal of this literature is that its mechanistic confidence rests heavily on animal models whose translation to humans is incomplete. No animal model fully mirrors human lung pathology in smoke inhalation injury, and all have limitations in replicating the clinical disease ^[19]. The ovine model itself lacks full standardization and requires a second-hit insult to reliably produce parenchymal ARDS ^[80], and at least one finding has failed to replicate across species. These caveats should temper how confidently any animal-derived mechanism is stated.

Several specific tensions run through the evidence. The early human extravascular-lung-water data appear to contradict the animal lymph-flow data, with clinical studies showing little early lung-water rise from inhalation alone and attributing delayed rises to sepsis ^[50]; the reconciliation is the airway-first, second-hit framing rather than a true contradiction. The attributable-mortality estimates span an implausibly wide 20 to 84 percent range across eras and likely overstate the effect in older series, with recent cohorts trending lower ^[28][26]. Carboxyhemoglobin, long treated as a dose marker, dissociates from histologic lung injury and cannot predict its degree ^[85]. Within outcomes, recent data contest whether early ARDS carries the mortality its severity grade would predict ^[101].

The diagnostic and prognostic apparatus is also unsettled. There is no worldwide consensus for the diagnosis, severity grading, or prognosis of inhalation injury ^[18], named research gaps include airway repair mechanisms, the post-injury airway microbiome, and candidate biomarkers ^[104], and a 2025 meta-analysis cautioned that heterogeneous and inconsistent grading methodology limits confidence in the grade-outcome associations that much of the prognostic literature rests on ^[82]. Therapeutically, the durable message is that no specific therapy exists ^[5] and that the mortality gains of recent decades came from general critical-care advances rather than targeted interventions ^[87], which is the clearest single statement of how much mechanistic understanding has and has not translated into treatment.

References¶

[1] Han ZH, Jiang Y, Duan YY, Wang XY, Huang Y, Fang TZ. "OXIDATIVE STRESS IN A RAT MODEL OF COTTON SMOKE INHALATION-INDUCED PULMONARY INJURY." African journal of traditional, complementary, and alternative medicines : AJTCAM 2016. PMID: 28487903 ↩

[2] Demling RH. "Smoke inhalation injury." New horizons (Baltimore, Md.) 1993. PMID: 7922421 ↩

[3] Pruitt BA, Cioffi WG. "Diagnosis and treatment of smoke inhalation." Journal of intensive care medicine 1995. PMID: 10155177 ↩

[4] Reske A, Bak Z, Samuelsson A, Morales O, Seiwerts M, Sjöberg F. "Computed tomography--a possible aid in the diagnosis of smoke inhalation injury?" Acta anaesthesiologica Scandinavica 2005. PMID: 15715631 ↩

[5] Haponik EF. "Clinical smoke inhalation injury: pulmonary effects." Occupational medicine (Philadelphia, Pa.) 1993. PMID: 8272974 ↩

[6] Lee AS, Mellins RB. "Lung injury from smoke inhalation." Paediatric respiratory reviews 2006. PMID: 16765298 ↩

[7] Mizutani A, Enkhbaatar P, Esechie A, Traber LD, Cox RA, Hawkins HK, et al.. "Pulmonary changes in a mouse model of combined burn and smoke inhalation-induced injury." Journal of applied physiology (Bethesda, Md. : 1985) 2008. PMID: 18436699 ↩

[8] LaLonde C, Ikegami K, Demling R. "Aerosolized deferoxamine prevents lung and systemic injury caused by smoke inhalation." Journal of applied physiology (Bethesda, Md. : 1985) 1994. PMID: 7532647 ↩

[9] Toon MH, Maybauer MO, Greenwood JE, Maybauer DM, Fraser JF. "Management of acute smoke inhalation injury." Critical care and resuscitation : journal of the Australasian Academy of Critical Care Medicine 2010. PMID: 20196715 ↩

[10] Herndon DN, Thompson PB, Traber DL. "Pulmonary injury in burned patients." Critical care clinics 1985. PMID: 3916776 ↩

[11] Lentz CW, Peterson HD. "Smoke inhalation is a multilevel insult to the pulmonary system." Current opinion in pulmonary medicine 1997. PMID: 9232369 ↩

[12] Cox CS, Zwischenberger JB, Traber DL, Traber LD, Haque AK, Herndon DN. "Heparin improves oxygenation and minimizes barotrauma after severe smoke inhalation in an ovine model." Surgery, gynecology & obstetrics 1993. PMID: 8460409 ↩

[13] Kramer GC, Herndon DN, Linares HA, Traber DL. "Effects of inhalation injury on airway blood flow and edema formation." The Journal of burn care & rehabilitation 1989. PMID: 2921258 ↩

[14] Herndon DN, Traber DL, Niehaus GD, Linares HA, Traber LD. "The pathophysiology of smoke inhalation injury in a sheep model." The Journal of trauma 1984. PMID: 6512897 ↩

[15] Cox RA, Burke AS, Soejima K, Murakami K, Katahira J, Traber LD, et al.. "Airway obstruction in sheep with burn and smoke inhalation injuries." American journal of respiratory cell and molecular biology 2003. PMID: 12936906 ↩

[16] Westphal M, Cox RA, Traber LD, Morita N, Enkhbaatar P, Schmalstieg FC, et al.. "Combined burn and smoke inhalation injury impairs ovine hypoxic pulmonary vasoconstriction." Critical care medicine 2006. PMID: 16540966 ↩

[17] Coston TD, Gaskins D, Bailey A, Minus E, Arbabi S, West TE, et al.. "Severity of Inhalation Injury and Risk of Nosocomial Pneumonia: A Retrospective Cohort Study." Chest 2024. PMID: 38964672 ↩

[18] Enkhbaatar P, Pruitt BA, Suman O, Mlcak R, Wolf SE, Sakurai H, et al.. "Pathophysiology, research challenges, and clinical management of smoke inhalation injury." Lancet (London, England) 2016. PMID: 27707500 ↩

[19] Reczyńska K, Tharkar P, Kim SY, Wang Y, Pamuła E, Chan HK, et al.. "Animal models of smoke inhalation injury and related acute and chronic lung diseases." Advanced drug delivery reviews 2018. PMID: 29108862 ↩

[20] Gore DC, Hawkins HK, Chinkes DL, Chung DH, Sanford AP, Herndon DN, et al.. "Assessment of adverse events in the demise of pediatric burn patients." The Journal of trauma 2007. PMID: 18090010 ↩

[21] Culnan DM, Craft-Coffman B, Bitz GH, Capek KD, Tu Y, Lineaweaver WC, et al.. "Carbon Monoxide and Cyanide Poisoning in the Burned Pregnant Patient: An Indication for Hyperbaric Oxygen Therapy." Annals of plastic surgery 2018. PMID: 29461288 ↩

[22] Foncerrada G, Culnan DM, Capek KD, González-Trejo S, Cambiaso-Daniel J, Woodson LC, et al.. "Inhalation Injury in the Burned Patient." Annals of plastic surgery 2018. PMID: 29461292 ↩

[23] Sood RF, Gibran NS, Arnoldo BD, Gamelli RL, Herndon DN, Tompkins RG. "Early leukocyte gene expression associated with age, burn size, and inhalation injury in severely burned adults." The journal of trauma and acute care surgery 2016. PMID: 26517785 ↩

[24] Ding Z, Zhuang Y, Zhao Y, Shi J, Guo X, Fan H, et al.. "Bone marrow mesenchymal stem cells alleviate smoke inhalation injury by regulating alveolar macrophage polarization via the CD200-CD200R pathway." Frontiers in immunology 2025. PMID: 41221273 ↩

[25] Maarouf R, Campbell C. "Acute respiratory failure and burn patient outcomes." Current opinion in anaesthesiology 2021. PMID: 33606398 ↩

[26] Sterner JB, Zanders TB, Morris MJ, Cancio LC. "Inflammatory mediators in smoke inhalation injury." Inflammation & allergy drug targets 2009. PMID: 19275694 ↩

[27] Endorf FW, Gamelli RL. "Inhalation injury, pulmonary perturbations, and fluid resuscitation." Journal of burn care & research : official publication of the American Burn Association 2007. PMID: 17211205 ↩

[28] Belli S, Basaran O, Ozdemir BH, Türkoğlu S, Karabay G, Kut A, et al.. "Protective role of simvastatin on lung damage caused by burn and cotton smoke inhalation in rats." The Journal of surgical research 2011. PMID: 20452610 ↩

[29] Pruitt BA, Cioffi WG, Shimazu T, Ikeuchi H, Mason AD. "Evaluation and management of patients with inhalation injury." The Journal of trauma 1990. PMID: 2254994 ↩

[30] Knowlin L, Stanford L, Cairns B, Charles A. "The effect of smoking status on burn inhalation injury mortality." Burns : journal of the International Society for Burn Injuries 2017. PMID: 27707642 ↩

[31] Afshar M, Burnham EL, Joyce C, Gagnon R, Dunn R, Albright JM, et al.. "Injury Characteristics and von Willebrand Factor for the Prediction of Acute Respiratory Distress Syndrome in Patients With Burn Injury: Development and Internal Validation." Annals of surgery 2019. PMID: 29697443 ↩

[32] Sutton T, Lenk I, Conrad P, Halerz M, Mosier M. "Severity of Inhalation Injury is Predictive of Alterations in Gas Exchange and Worsened Clinical Outcomes." Journal of burn care & research : official publication of the American Burn Association 2017. PMID: 28570316 ↩

[33] Herndon DN, Barrow RE, Linares HA, Rutan RL, Prien T, Traber LD, et al.. "Inhalation injury in burned patients: effects and treatment." Burns, including thermal injury 1988. PMID: 3228693 ↩

[34] Traber DL, Linares HA, Herndon DN, Prien T. "The pathophysiology of inhalation injury--a review." Burns, including thermal injury 1988. PMID: 3067821 ↩

[35] Zhao R, Di LN, Zhao XZ, Wang C, Zhang GA. "Measuring surface temperature and grading pathological changes of airway tissue in a canine model of inhalational thermal injury." Burns : journal of the International Society for Burn Injuries 2013. PMID: 23164648 ↩

[36] Haponik EF, Meyers DA, Munster AM, Smith PL, Britt EJ, Wise RA, et al.. "Acute upper airway injury in burn patients. Serial changes of flow-volume curves and nasopharyngoscopy." The American review of respiratory disease 1987. PMID: 3813197 ↩

[37] Barrow RE, Wang CZ, Cox RA, Evans MJ. "Cellular sequence of tracheal repair in sheep after smoke inhalation injury." Lung 1992. PMID: 1434783 ↩

[38] Jacob S, Kraft R, Zhu Y, Jacob RK, Herndon DN, Traber DL, et al.. "Acute secretory cell toxicity and epithelial exfoliation after smoke inhalation injury in sheep: an electron and light microscopic study." Toxicology mechanisms and methods 2010. PMID: 20843269 ↩

[39] Murakami K, McGuire R, Cox RA, Jodoin JM, Schmalstieg FC, Traber LD, et al.. "Recombinant antithrombin attenuates pulmonary inflammation following smoke inhalation and pneumonia in sheep." Critical care medicine 2003. PMID: 12576969 ↩

[40] Shimazu T, Ogura H, Sugimoto H. "[Clinical and pathophysiologic problems associated with smoke inhalation injury]." Nihon Geka Gakkai zasshi 1998. PMID: 9547747 ↩

[41] Abdi S, Herndon D, McGuire J, Traber L, Traber DL. "Time course of alterations in lung lymph and bronchial blood flows after inhalation injury." The Journal of burn care & rehabilitation 1990. PMID: 2286604 ↩

[42] Hamahata A, Enkhbaatar P, Sakurai H, Nozaki M, Traber DL. "Sclerosis therapy of bronchial artery attenuates acute lung injury induced by burn and smoke inhalation injury in ovine model." Burns : journal of the International Society for Burn Injuries 2010. PMID: 20381969 ↩

[43] Hinder F, Matsumoto N, Booke M, Bradford DW, Traber LD, Herndon DN, et al.. "Inhalation injury increases the anastomotic bronchial blood flow in the pouch model of the left ovine lung." Shock (Augusta, Ga.) 1997. PMID: 9261904 ↩

[44] Soejima K, McGuire R, Snyder N, Uchida T, Szabó C, Salzman A, et al.. "The effect of inducible nitric oxide synthase (iNOS) inhibition on smoke inhalation injury in sheep." Shock (Augusta, Ga.) 2000. PMID: 10774613 ↩

[45] Nakazawa H, Gustafsson TO, Traber LD, Herndon DN, Traber DL. "alpha-Trinositol decreases lung edema formation after smoke inhalation in an ovine model." Journal of applied physiology (Bethesda, Md. : 1985) 1994. PMID: 8175518 ↩

[46] Isago T, Noshima S, Traber LD, Herndon DN, Traber DL. "Analysis of pulmonary microvascular permeability after smoke inhalation." Journal of applied physiology (Bethesda, Md. : 1985) 1991. PMID: 1757363 ↩

[47] Schenk WG, Aldridge SC, Farley PC. "Experimental inhalation injury with concomitant surface burn: dextran resuscitation improves lung water and oxygenation." The Journal of trauma 1990. PMID: 1696323 ↩

[48] Lalonde C, Knox J, Youn YK, Demling R. "Burn edema is accentuated by a moderate smoke inhalation injury in sheep." Surgery 1992. PMID: 1440244 ↩

[49] Soejima K, Schmalstieg FC, Sakurai H, Traber LD, Traber DL. "Pathophysiological analysis of combined burn and smoke inhalation injuries in sheep." American journal of physiology. Lung cellular and molecular physiology 2001. PMID: 11350803 ↩

[50] Tranbaugh RF, Lewis FR, Christensen JM, Elings VB. "Lung water changes after thermal injury. The effects of crystalloid resuscitation and sepsis." Annals of surgery 1980. PMID: 7425695 ↩

[51] Burns TR, Greenberg SD, Cartwright J, Jachimczyk JA. "Smoke inhalation: an ultrastructural study of reaction to injury in the human alveolar wall." Environmental research 1986. PMID: 3780643 ↩

[52] Laffon M, Pittet JF, Modelska K, Matthay MA, Young DM. "Interleukin-8 mediates injury from smoke inhalation to both the lung endothelial and the alveolar epithelial barriers in rabbits." American journal of respiratory and critical care medicine 1999. PMID: 10556103 ↩

[53] Nieman GF, Clark WR, Wax SD, Webb SR. "The effect of smoke inhalation on pulmonary surfactant." Annals of surgery 1980. PMID: 6892674 ↩

[54] Nieman GF, Paskanik AM, Fluck RR, Clark WR. "Comparison of exogenous surfactants in the treatment of wood smoke inhalation." American journal of respiratory and critical care medicine 1995. PMID: 7633713 ↩

[55] Feldbaum DM, Wormuth D, Nieman GF, Paskanik M, Clark WR, Hakim TS. "Exosurf treatment following wood smoke inhalation." Burns : journal of the International Society for Burn Injuries 1993. PMID: 8216766 ↩

[56] Soejima K, Traber LD, Schmalstieg FC, Hawkins H, Jodoin JM, Szabo C, et al.. "Role of nitric oxide in vascular permeability after combined burns and smoke inhalation injury." American journal of respiratory and critical care medicine 2001. PMID: 11254534 ↩

[57] Enkhbaatar P, Connelly R, Wang J, Nakano Y, Lange M, Hamahata A, et al.. "Inhibition of neuronal nitric oxide synthase in ovine model of acute lung injury." Critical care medicine 2009. PMID: 19050603 ↩

[58] Westphal M, Enkhbaatar P, Schmalstieg FC, Kulp GA, Traber LD, Morita N, et al.. "Neuronal nitric oxide synthase inhibition attenuates cardiopulmonary dysfunctions after combined burn and smoke inhalation injury in sheep." Critical care medicine 2008. PMID: 18379246 ↩

[59] Lange M, Szabo C, Enkhbaatar P, Connelly R, Horvath E, Hamahata A, et al.. "Beneficial pulmonary effects of a metalloporphyrinic peroxynitrite decomposition catalyst in burn and smoke inhalation injury." American journal of physiology. Lung cellular and molecular physiology 2011. PMID: 21075825 ↩

[60] Traber DL, Hawkins HK, Enkhbaatar P, Cox RA, Schmalstieg FC, Zwischenberger JB, et al.. "The role of the bronchial circulation in the acute lung injury resulting from burn and smoke inhalation." Pulmonary pharmacology & therapeutics 2007. PMID: 16798035 ↩

[61] Murakami K, Enkhbaatar P, Yu YM, Traber LD, Cox RA, Hawkins HK, et al.. "L-arginine attenuates acute lung injury after smoke inhalation and burn injury in sheep." Shock (Augusta, Ga.) 2007. PMID: 17558346 ↩

[62] Demling R, Lalonde C, Picard L, Blanchard J. "Changes in lung and systemic oxidant and antioxidant activity after smoke inhalation." Shock (Augusta, Ga.) 1994. PMID: 7749927 ↩

[63] Demling RH, Knox J, Youn YK, LaLonde C. "Oxygen consumption early postburn becomes oxygen delivery dependent with the addition of smoke inhalation injury." The Journal of trauma 1992. PMID: 1588648 ↩

[64] Morita N, Shimoda K, Traber MG, Westphal M, Enkhbaatar P, Murakami K, et al.. "Vitamin E attenuates acute lung injury in sheep with burn and smoke inhalation injury." Redox report : communications in free radical research 2006. PMID: 16686996 ↩

[65] Niehaus GD, Kimura R, Traber LD, Herndon DN, Flynn JT, Traber DL. "Administration of a synthetic antiprotease reduces smoke-induced lung injury." Journal of applied physiology (Bethesda, Md. : 1985) 1990. PMID: 1699920 ↩

[66] Xie EF. "[Experimental study of dynamic changes in elastase-antiprotease in rabbits in the early stage of inhalation injury]." Zhonghua zheng xing shao shang wai ke za zhi = Zhonghua zheng xing shao shang waikf [i.e. waike] zazhi = Chinese journal of plastic surgery and burns 1989. PMID: 2517241 ↩

[67] Loick HM, Traber LD, Tokyay R, Linares HA, Rogers S, Flynn JT, et al.. "Thromboxane receptor blockade with BM 13,177 following toxic airway damage by smoke inhalation in sheep." European journal of pharmacology 1993. PMID: 8339755 ↩

[68] Wright MJ, Murphy JT. "Smoke inhalation enhances early alveolar leukocyte responsiveness to endotoxin." The Journal of trauma 2005. PMID: 16096540 ↩

[69] Bartha E, Asmussen S, Olah G, Rehberg SW, Yamamoto Y, Traber DL, et al.. "Burn and smoke injury activates poly(ADP-ribose)polymerase in circulating leukocytes." Shock (Augusta, Ga.) 2011. PMID: 21330947 ↩

[70] Herlihy JP, Vermeulen MW, Joseph PM, Hales CA. "Impaired alveolar macrophage function in smoke inhalation injury." Journal of cellular physiology 1995. PMID: 7896885 ↩

[71] Ogura H, Saitoh D, Johnson AA, Mason AD, Pruitt BA, Cioffi WG. "The effect of inhaled nitric oxide on pulmonary ventilation-perfusion matching following smoke inhalation injury." The Journal of trauma 1994. PMID: 7996601 ↩

[72] Robinson NB, Hudson LD, Robertson HT, Thorning DR, Carrico CJ, Heimbach DM. "Ventilation and perfusion alterations after smoke inhalation injury." Surgery 1981. PMID: 7256547 ↩

[73] Demling R, Lalonde C, Youn YK, Picard L. "Effect of graded increases in smoke inhalation injury on the early systemic response to a body burn." Critical care medicine 1995. PMID: 8001368 ↩

[74] Sugi K, Theissen JL, Traber LD, Herndon DN, Traber DL. "Impact of carbon monoxide on cardiopulmonary dysfunction after smoke inhalation injury." Circulation research 1990. PMID: 2295145 ↩

[75] Soejima K, Schmalstieg FC, Traber LD, Szabo C, Salzman A, Traber DL. "Role of nitric oxide in myocardial dysfunction after combined burn and smoke inhalation injury." Burns : journal of the International Society for Burn Injuries 2001. PMID: 11718983 ↩

[76] Morris SE, Navaratnam N, Herndon DN. "A comparison of effects of thermal injury and smoke inhalation on bacterial translocation." The Journal of trauma 1990. PMID: 2352293 ↩

[77] Herndon DN, Traber LD, Linares H, Flynn JD, Niehaus G, Kramer G, et al.. "Etiology of the pulmonary pathophysiology associated with inhalation injury." Resuscitation 1986. PMID: 3024279 ↩

[78] Linares HA, Herndon DN, Traber DL. "Sequence of morphologic events in experimental smoke inhalation." The Journal of burn care & rehabilitation 1989. PMID: 2921256 ↩

[79] Yamamoto Y, Enkhbaatar P, Sakurai H, Rehberg S, Asmussen S, Ito H, et al.. "Development of a long-term ovine model of cutaneous burn and smoke inhalation injury and the effects of early excision and skin autografting." Burns : journal of the International Society for Burn Injuries 2012. PMID: 22459154 ↩

[80] Ballard-Croft C, Sumpter LR, Broaddus R, Alexander J, Wang D, Zwischenberger JB. "Ovine smoke/burn ARDS model: a new ventilator-controlled smoke delivery system." The Journal of surgical research 2010. PMID: 20828741 ↩

[81] Stone HH. "Pulmonary burns in children." Journal of pediatric surgery 1979. PMID: 423063 ↩

[82] Amarasekera NN, Jha A, Charles WN, Dutt A, Milton-Jones H, Kumana E, et al.. "Evaluating the association between bronchoscopic severity of burns-related smoke inhalation injury and clinical outcomes: A systematic review and meta-analysis." Burns : journal of the International Society for Burn Injuries 2025. PMID: 41101183 ↩

[83] Chou SH, Lin SD, Chuang HY, Cheng YJ, Kao EL, Huang MF. "Fiber-optic bronchoscopic classification of inhalation injury: prediction of acute lung injury." Surgical endoscopy 2004. PMID: 15164282 ↩

[84] Nie L, Gao Z, Li Y. "[Changes in blood gas in burned patients in Xining]." Zhonghua zheng xing shao shang wai ke za zhi = Zhonghua zheng xing shao shang waikf [i.e. waike] zazhi = Chinese journal of plastic surgery and burns 1996. PMID: 8758732 ↩

[85] Lange M, Cox RA, Enkhbaatar P, Whorton EB, Nakano Y, Hamahata A, et al.. "Predictive role of arterial carboxyhemoglobin concentrations in ovine burn and smoke inhalation-induced lung injury." Experimental lung research 2011. PMID: 21309735 ↩

[86] Mosier MJ, Pham TN, Park DR, Simmons J, Klein MB, Gibran NS. "Predictive value of bronchoscopy in assessing the severity of inhalation injury." Journal of burn care & research : official publication of the American Burn Association 2012. PMID: 21941194 ↩

[87] Dries DJ, Endorf FW. "Inhalation injury: epidemiology, pathology, treatment strategies." Scandinavian journal of trauma, resuscitation and emergency medicine 2013. PMID: 23597126 ↩

[88] Darling GE, Keresteci MA, Ibañez D, Pugash RA, Peters WJ, Neligan PC. "Pulmonary complications in inhalation injuries with associated cutaneous burn." The Journal of trauma 1996. PMID: 8577005 ↩

[89] Cox CS, Zwischenberger JB, Traber DL, Minifee PK, Navaratnam N, Haque AK, et al.. "Immediate positive pressure ventilation with positive end-expiratory pressure (PEEP) improves survival in ovine smoke inhalation injury." The Journal of trauma 1992. PMID: 1474622 ↩

[90] Enkhbaatar P, Murakami K, Cox R, Westphal M, Morita N, Brantley K, et al.. "Aerosolized tissue plasminogen inhibitor improves pulmonary function in sheep with burn and smoke inhalation." Shock (Augusta, Ga.) 2004. PMID: 15201705 ↩

[91] Nieman GF, Clark WR, Hakim T. "Methylprednisolone does not protect the lung from inhalation injury." Burns : journal of the International Society for Burn Injuries 1991. PMID: 1760107 ↩

[92] Cox RA, Jacob S, Zhu Y, Mlcak R, Kraft R, Herndon DN, et al.. "Airway obstruction and bacterial invasion in autopsy tissue of pediatric burn victims." Journal of burn care & research : official publication of the American Burn Association 2014. PMID: 24503967 ↩

[93] Kraft R, Herndon DN, Mlcak RP, Finnerty CC, Cox RA, Williams FN, et al.. "Bacterial respiratory tract infections are promoted by systemic hyperglycemia after severe burn injury in pediatric patients." Burns : journal of the International Society for Burn Injuries 2014. PMID: 24074819 ↩

[94] Jones WG, Madden M, Finkelstein J, Yurt RW, Goodwin CW. "Tracheostomies in burn patients." Annals of surgery 1989. PMID: 2930291 ↩

[95] Tasaka S, Kanazawa M, Mori M, Fujishima S, Ishizaka A, Yamasawa F, et al.. "Long-term course of bronchiectasis and bronchiolitis obliterans as late complication of smoke inhalation." Respiration; international review of thoracic diseases 1995. PMID: 7716354 ↩

[96] Goretsky MJ, Greenhalgh DG, Warden GD, Ryckman FC, Warner BW. "The use of extracorporeal life support in pediatric burn patients with respiratory failure." Journal of pediatric surgery 1995. PMID: 7595848 ↩

[97] Ben DF, Ma B, Chen XL, Zhu SH, Tang HT, Lu W, et al.. "Burn injuries caused by ship fire: a 12-year study in Shanghai." Burns : journal of the International Society for Burn Injuries 2010. PMID: 19819636 ↩

[98] Huang KL, Chen CW, Chu SJ, Perng WC, Wu CP. "Systemic inflammation caused by white smoke inhalation in a combat exercise." Chest 2008. PMID: 18198249 ↩

[99] Belenkiy SM, Buel AR, Cannon JW, Sine CR, Aden JK, Henderson JL, et al.. "Acute respiratory distress syndrome in wartime military burns: application of the Berlin criteria." The journal of trauma and acute care surgery 2014. PMID: 24553555 ↩

[100] Bordes J, Lacroix G, Esnault P, Goutorbe P, Cotte J, Dantzer E, et al.. "Comparison of the Berlin definition with the American European consensus definition for acute respiratory distress syndrome in burn patients." Burns : journal of the International Society for Burn Injuries 2014. PMID: 24685349 ↩

[101] Sjoberg F, Elmasry M, Abdelrahman I, Nyberg G, T-Elserafi A, Ursing E, et al.. "The impact and validity of the Berlin criteria on burn-induced ARDS: Examining mortality rates, and inhalation injury influences. A single center observational cohort study." Burns : journal of the International Society for Burn Injuries 2024. PMID: 38777667 ↩

[102] Maybauer DM, Traber DL, Radermacher P, Herndon DN, Maybauer MO. "[Treatment strategies for acute smoke inhalation injury]." Der Anaesthesist 2006. PMID: 16826418 ↩

[103] Hollingsed TC, Saffle JR, Barton RG, Craft WB, Morris SE. "Etiology and consequences of respiratory failure in thermally injured patients." American journal of surgery 1993. PMID: 8273836 ↩

[104] Dyamenahalli K, Garg G, Shupp JW, Kuprys PV, Choudhry MA, Kovacs EJ. "Inhalation Injury: Unmet Clinical Needs and Future Research." Journal of burn care & research : official publication of the American Burn Association 2019. PMID: 31214710 ↩

[105] Mason SA, Nathens AB, Byrne JP, Fowler R, Gonzalez A, Karanicolas PJ, et al.. "The accuracy of burn diagnosis codes in health administrative data: A validation study." Burns : journal of the International Society for Burn Injuries 2017. PMID: 28069344 ↩